BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10757075)

  • 1. Microarray-based expression profiling in prostate tumors.
    Elek J; Park KH; Narayanan R
    In Vivo; 2000; 14(1):173-82. PubMed ID: 10757075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.
    Xu J; Stolk JA; Zhang X; Silva SJ; Houghton RL; Matsumura M; Vedvick TS; Leslie KB; Badaro R; Reed SG
    Cancer Res; 2000 Mar; 60(6):1677-82. PubMed ID: 10749139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections.
    Thelen P; Burfeind P; Grzmil M; Voigt S; Ringert RH; Hemmerlein B
    Int J Oncol; 2004 May; 24(5):1085-92. PubMed ID: 15067329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
    Schlomm T; Luebke AM; Sültmann H; Hellwinkel OJ; Sauer U; Poustka A; David KA; Chun FK; Haese A; Graefen M; Erbersdobler A; Huland H
    Int J Oncol; 2005 Sep; 27(3):713-20. PubMed ID: 16077921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
    Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
    Ding Y; Xu L; Chen S; Jovanovic BD; Helenowski IB; Kelly DL; Catalona WJ; Yang XJ; Pins M; Ananthanarayanan V; Bergan RC
    Prostate Cancer Prostatic Dis; 2006; 9(4):379-91. PubMed ID: 16786039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
    Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
    Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
    Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
    Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
    Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevant genomics of neurotensin receptor in cancer.
    Elek J; Pinzon W; Park KH; Narayanan R
    Anticancer Res; 2000; 20(1A):53-8. PubMed ID: 10769634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
    Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
    Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray.
    Kim TM; Jeong HJ; Seo MY; Kim SC; Cho G; Park CH; Kim TS; Park KH; Chung HC; Rha SY
    Clin Cancer Res; 2005 Jan; 11(1):79-86. PubMed ID: 15671531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of cDNA microarray technology and analysis of gene expression profiles in human esophageal cancer cell line ECa109].
    Li P; Ling Z; Zhao J; Yang H; Huang Y; Zhao M; Dong Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):413-8. PubMed ID: 18610633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
    Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
    Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes associated with tumor progression using microarrays.
    Gebauer G; Krones-Herzig A; Glinskii AB; Glinsky GV
    Anticancer Res; 2005; 25(3A):1477-82. PubMed ID: 16033048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.